Immunology
Biomarkers Evaluated for Lung Disease Severity in Cystic Fibrosis
Cystic fibrosis (CF) is one of the most common life-shortening monogenic disorders amongst European-derived populations currently affecting more than 85,000 patients worldwide. The diagnosis of CF is based on consensus clinical and laboratory criteria. More...22 Jun 2020
Two Serodiagnostic Tests Compared for Loiasis in Non-Endemic Area
Loiasis, the disease caused by the infection with the filarial nematode Loa loa, is transmitted through the bite of tabanid flies of the genus Chrysops. It is endemic in Central and West Africa where, according to the most recent estimates, about 10 million people are infected. More...18 Jun 2020
Increasingly Efficient Serological Tests Developed with Electrochemiluminescence
Diagnostic markers, or biomarkers, are biomolecules (e.g., enzymes, proteins, peptides, and hormones) that can be measured accurately and reproducibly and can precisely predict relevant clinical outcomes or diseases in various populations. More...17 Jun 2020
Tumor Mutation and Immune Microenvironment Revealed in Colorectal Cancer
Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Other risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. More...10 Jun 2020
Serological Exposure Markers Developed for Vivax Malaria
Plasmodium vivax is the most widespread malaria parasite worldwide, with up to two billion people at risk of infection. As well as causing illness and death in its 'active' stage of infection, the parasite can hide as hypnozoites, a dormant stage, in the liver, and is a significant cause of 'relapsing' malaria. More...10 Jun 2020
Cytokine Signatures of Tertian Malaria Infection Profiled During Pregnancy
Malaria caused by Plasmodium vivax is a neglected tropical disease, especially during pregnancy, of worldwide distribution. P. vivax is a protozoal parasite and a human pathogen. This parasite is the most frequent and widely distributed cause of recurring malaria. More...27 May 2020
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Slide Scanner System
NanoZoomer S540MD
In Other News
Silver Nanocubes Make Point-of-Care Diagnostics Easier to Read
Initial Immune Response After Dengue Virus Infection Identified
Immune Microenvironment Changes Contribute to Early-Stage Multiple Myeloma
Immune Responses Evaluated for Tick-Borne Encephalitis
High-Throughput T Cell Profiling Technique Developed
Antibody Detection Is Critical for COVID-19 Diagnosis
Blood Biomarkers Help Diagnose Parkinson's Disease
Molecular Differences Discovered Among Ovarian Cancer Subgroups
Urea Dissociation Tests Reduces SARS-CoV-2 IgM False-Positives
Human NK Cells Identified by Single-Cell RNA Sequencing
Biomarker Panel Evaluated for Primary Hyperoxaluria Patients
Functional Comparison of Different Tubes for Isolating Mononuclear Cells
Missing BAP1 Gene Associated with Immunosuppressive Molecules in Uveal Melanoma
Commercial Kits Evaluated for Mediterranean Visceral Leishmaniasis
Novel Glycoprotein Biomarker Evaluated for Liver Fibrosis
sTNFR2 Revealed as a Novel Diagnostic Biomarker for Acute ATL
Ultra-Fast Cycling for Multiplexed Cellular Fluorescence Imaging
Deep Throat SARS-CoV-2 Viral Load Ascertained in Saliva Samples
Molecule in Lymphatic System Implicated in Autoimmune Diseases
Factors Associated with ARDS in COVID-19 Identified
SARS-Cov-2 Specific Antibody Responses in COVID-19 Patients
Fibrinogen-Albumin Ratio Correlated to Ankylosing Spondylitis Disease Activity
Combining Biomarkers Predicts Metastasis in Medullary Thyroid Carcinoma
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.